Nadler Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$381K Sell
15,802
-193
-1% -$5.05K 0.03% 104
2026
Q1
$449K Sell
15,995
-657
-4% -$17.5K 0.04% 88
2025
Q4
$415K Sell
16,652
-4,483
-21% -$113K 0.04% 91
2025
Q3
$539K Sell
21,135
-3,422
-14% -$84.5K 0.05% 77
2025
Q2
$595K Sell
24,557
-1,797
-7% -$41.9K 0.06% 68
2025
Q1
$668K Buy
26,354
+1,145
+5% +$30K 0.07% 59
2024
Q4
$669K Sell
25,209
-2,723
-10% -$73.9K 0.07% 59
2024
Q3
$808K Buy
27,932
+519
+2% +$15.1K 0.09% 52
2024
Q2
$767K Buy
27,413
+4
+0% +$110 0.09% 52
2024
Q1
$761K Buy
27,409
+202
+0.7% +$5.61K 0.09% 53
2023
Q4
$783K Sell
27,207
-1,712
-6% -$51.8K 0.11% 49
2023
Q3
$959K Sell
28,919
-970
-3% -$34.3K 0.15% 47
2023
Q2
$1.1M Sell
29,889
-102
-0.3% -$3.97K 0.16% 44
2023
Q1
$1.22M Sell
29,991
-974
-3% -$42.1K 0.19% 44
2022
Q4
$1.59M Buy
30,965
+21
+0.1% +$1.01K 0.28% 35
2022
Q3
$1.35M Sell
30,944
-1,204
-4% -$58.5K 0.26% 37
2022
Q2
$1.69M Buy
32,148
+16
+0% +$815 0.31% 35
2022
Q1
$1.66M Sell
32,132
-352
-1% -$18.3K 0.26% 39
2021
Q4
$1.92M Sell
32,484
-781
-2% -$38.7K 0.28% 40
2021
Q3
$1.43M Buy
33,265
+360
+1% +$15.9K 0.23% 43
2021
Q2
$1.29M Sell
32,905
-1,162
-3% -$45.2K 0.21% 43
2021
Q1
$1.23M Sell
34,067
-44
-0.1% -$1.56K 0.22% 42
2020
Q4
$1.26M Buy
34,111
+814
+2% +$29.9K 0.24% 37
2020
Q3
$1.16M Buy
33,297
+4,251
+15% +$149K 0.26% 38
2020
Q2
$901K Sell
29,046
-522
-2% -$17.7K 0.23% 40
2020
Q1
$916K Sell
29,568
-1,657
-5% -$56.5K 0.28% 34
2019
Q4
$1.16M Sell
31,225
-277
-0.9% -$9.87K 0.29% 34
2019
Q3
$1.07M Sell
31,502
-1,294
-4% -$47.1K 0.3% 32
2019
Q2
$1.35M Sell
32,796
-151
-0.5% -$6K 0.39% 26
2019
Q1
$1.33M Sell
32,947
-792
-2% -$31.7K 0.42% 26
2018
Q4
$1.4M Sell
33,739
-376
-1% -$15.6K 0.46% 24
2018
Q3
$1.43M Buy
34,115
+51
+0.1% +$1.96K 0.39% 25
2018
Q2
$1.17M Buy
34,064
+2,770
+9% +$94.7K 0.33% 31
2018
Q1
$1.05M Sell
31,294
-3,373
-10% -$116K 0.32% 28
2017
Q4
$1.19M Sell
34,667
-301
-0.9% -$10.3K 0.36% 29
2017
Q3
$1.18M Buy
34,968
+60
+0.2% +$1.93K 0.39% 26
2017
Q2
$1.11M Buy
34,908
+1,455
+4% +$45.9K 0.38% 26
2017
Q1
$1.09M Sell
33,453
-1,863
-5% -$58.7K 0.38% 28
2016
Q4
$1.09M Buy
35,316
+4,417
+14% +$135K 0.4% 26
2016
Q3
$993K Sell
30,899
-249
-0.8% -$8.33K 0.39% 27
2016
Q2
$1.04M Sell
31,148
-115
-0.4% -$3.67K 0.44% 24
2016
Q1
$879K Buy
31,263
+29
+0.1% +$828 0.38% 26
2015
Q4
$957K Buy
31,234
+23
+0.1% +$724 0.43% 25
2015
Q3
$930K Buy
31,211
+414
+1% +$13.3K 0.47% 22
2015
Q2
$980K Sell
30,797
-2,895
-9% -$94.4K 0.46% 24
2015
Q1
$1.11M Sell
33,692
-86
-0.3% -$2.73K 0.53% 22
2014
Q4
$998K Buy
33,778
+983
+3% +$28.2K 0.52% 21
2014
Q3
$920K Sell
32,795
-624
-2% -$17.5K 0.55% 21
2014
Q2
$941K Buy
33,419
+183
+0.6% +$5.22K 0.59% 19
2014
Q1
$1.01M Sell
33,236
-1,642
-5% -$49K 0.67% 18
2013
Q4
$1.01M Sell
34,878
-841
-2% -$24.5K 0.66% 19
2013
Q3
$973K Sell
35,719
-6,955
-16% -$189K 0.71% 22
2013
Q2
$1.13M Buy
+42,674
New +$1.18M 0.8% 18

Other funds holding PFE

Nadler Financial Group's PFE Position: Q2 2026 in Review

Nadler Financial Group reduced its Pfizer (PFE) stake by 1.2% in Q2 2026, selling an estimated $5.05K and leaving 15,802 shares worth $381K. The position accounts for 0.03% of the portfolio, ranked #104.

Nadler Financial Group first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.92M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Nadler Financial Group held 15,802 shares of Pfizer worth $381K as of Q2 2026.
  • Nadler Financial Group sold 193 Pfizer shares in Q2 2026, an estimated $5.05K.
  • Pfizer made up 0.03% of Nadler Financial Group's portfolio in Q2 2026, its #104 holding.
  • Nadler Financial Group first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Nadler Financial Group's Pfizer position peaked at $1.92M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Nadler Financial Group's 13F filing for Q2 2026, filed 30 Jul 2026.